Fiche du document
3 mars 2021
- doi: 10.53738/REVMED.2021.17.728.0434
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2021.17.728.0434
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/33656296
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_3A8233AA39B69
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
TherapyCiter ce document
S. Aur et al., « Cardio-oncologie : une discipline en devenir [Cardio-oncology : a specialty for the future] », Serveur académique Lausannois, ID : 10.53738/REVMED.2021.17.728.0434
Métriques
Partage / Export
Résumé
Cardio-oncology is a specialty that has rapidly progressed during the last decade. Modern cancer therapies have shown a significant positive impact on the survival of cancer patients. Alongside the progress in oncological treatments came a wide array of cardiac toxicities. The development of cardiotoxicity can lead to unfortunate outcomes. Ensuring the optimal oncological treatment while protecting the heart and vascular system constitute the main objectives of the cardio-oncology unit. Its purpose is to prevent, treat and provide adequate follow-up of patients subject to cardiotoxic drugs.